Inno, A., Bogina, G., Settanni, G., Salgarello, M., Foti, G., Pomari, C., Picece, V., & Gori, S. (2023). First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression. Drug Target Insights, 17(1), 110–113. https://doi.org/10.33393/dti.2023.2626